New form of immunotherapy for blood cancer patients

Blood cancers are the fourth most common form in the U.S. Relapse is common and treatment can be tough. A new form of immunotherapy is showing great promise. Hematologist and oncologist Doctor Joshua Mansour explains how the immune system plays a role in how cancer develops and describes Car T-cell treatment therapy.